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ABSTRACT 
 
The burning of selected indigenous plants and the inhalation of the smoke liberated from 
them  has been a widely accepted and practised form of administration in traditional healing 
therapy dating back to as far as the Koi and San, and is a method still widely practised in 
South Africa today. Inhalation has various advantages as a method of administration in both 
allopathic and traditional practices. Not only is inhalation a highly effective mode of 
administration because of its direct and local effect on the lungs for the treatment of 
respiratory ailments, but also because of its ability to deliver drugs effectively systemically. 
This study elucidated the rationale behind this widely practised treatment by examining 
chromatographic and antimicrobial data. Five plants that are commonly administered 
traditionally through inhalation were chosen: Heteropyxis natalensis, Myrothamnus 
flabellifolius, Artemisia afra, Pellaea calomelanos, and Tarchonanthus camphoratus. An 
apparatus was designed and constructed and the burning process that occurs in the traditional 
setting was simulated with the selected plants. The induced volatile fraction (smoke) was 
captured for analysis. Control solvent extracts were made for each plant using conventional 
extraction solvents, methanol, acetone, water, and the essential oil of the aromatic plants was 
also investigated. Antimicrobial assays revealed that the extracts (smoke) obtained after 
burning had lower minimum inhibitory concentration (MIC) values than the corresponding 
solvent extracts in most cases. For Klebsiella pneumoniae all five inhalation samples were far 
more active than the conventional extracts. When tested against the pathogen B. cereus, M. 
flabellifolius and P. calomelanos inhalation samples proved to exhibit superior antimicrobial 
activity compared to the respective solvent extracts. Pellaea calomelanos inhalation extract 
had the lowest MIC values compared to the solvent extracts for all pathogens (P. 
calomelanos inhalation extract MIC values: 0.53; 1.00; 0.53; 0.53 mg/ml for S. aureus, B. 
cereus, K. pneumoniae and C. neoformans respectively). Inhalation extracts exhibited 
different chemical profiles from the solvent extracts of the same plant. For example, A. afra 
inhalation extract had an abundance of peaks at various retention times from 3.2 to 5.4 
minutes, which were not present in the chromatograms of the acetone and methanol extracts 
of the same plant. These results, albeit preliminary, suggest that the chemistry and 
antimicrobial activity of plants are influenced by the combustion process which is often used 
in traditional healing rites.  
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PREFACE 
Medicinal plants have been used for their curative properties by traditional healers for 
centuries (Hutchings, 1996; van Wyk et al., 1997). The literature documents the use of plants 
for a range of conditions and, as a consequence, Western scientists have become increasingly 
interested in the rationale behind the use of traditional remedies. There are many ways in 
which medicinal plants may be administered. One of these is inhalation, which is widely 
practiced and is an area that warrants investigation. 
 
 Inhalation therapy often involves the burning of plant material and the smoke liberated 
during the process is either inhaled under covering or directed to a specific body part to aid in 
the healing process. Inhalation of smoke from burning plant matter is a unique method of 
administration and has been used traditionally to treat respiratory conditions such as asthma, 
bronchitis, influenza, respiratory infections and the common cold (Hutchings, 1996; van Wyk 
et al., 1997). Aerosol delivery of drugs is also well practised in allopathic medicine and has 
the advantage of being site specific thus enhancing the therapeutic ratio for respiratory 
ailments (Dipiro et al., 2002). 
 
 Generally, only the extracts or essential oils of the plant used in healing rituals described 
above have been investigated. In order to ensure a true investigation into inhalation therapy, 
the volatile fractions need to be captured and analysed, so as to determine whether the mode 
of administration, i.e. burning, has an impact on the pharmacological efficacy. It is 
hypothesised that burning liberates certain compounds (perhaps artefacts), which may affect 
the activity. 
 
The objective of this study was to mimic the burning process in the laboratory, obtain extracts 
after burning, and compare these to extracts not subjected to burning. Bioassays facilitated a 
comparison of the antimicrobial activities of inhalation extracts compared to those of 
conventional solvent extracts. Chromatographic profiles of extracts before and after burning 
were also undertaken. Such comparisons of constituents before and after the burning process 
would provide valuable information on the change in chemical composition and biological 
activity occurring during combustion, and would give insight into the benefits of inhalation as 
a common mode of administration practised in traditional healing rites. 
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CHAPTER 1: INTRODUCTION 
 
The delivery of drugs to the respiratory tract has become an increasingly important way of 
treatment in medical spheres. Inhalation of drugs has become invaluable therapeutically in 
the treatment of a variety of pulmonary disorders including asthma, bronchitis, pneumonia 
and cystic fibrosis (Suarez and Hickey, 2000).  
 
 It is common practice in traditional healing to burn plants and inhale the resultant smoke to 
treat respiratory complaints including coughs, colds, infections, influenza and asthma 
(Hutchings, 1996; van Wyk et al., 1997). Even though administration through inhalation 
dates back to the earliest records of ancient cultures and its techniques may be viewed as 
crude and unrefined, the advantages of this form of treatment have essentially remained the 
same. Several studies have shown the clinical efficacy of inhalation therapy for the treatments 
of lung disorders (Neville et al., 1977; Clarke, 1972). The delivery of active compounds 
directly to the lungs provides a local treatment and effectively delivers the drug to the site of 
action. In this way, smaller doses are able to achieve a maximal therapeutic effect and have 
less risk of side-effects than those associated with larger doses. Secondly, the lower doses 
provide considerable cost savings and reduce systemic exposure to patients (Suarez and 
Hickey, 2000). In addition, it has also been noted that the lungs may provide a perfect organ 
system for systemic delivery of drugs to the body (Suarez and Hickey, 2000). Suarez and 
Hickey (2000) have cited studies that show that this mode of administration provides 
substantially greater bioavailability for macromolecules than any other site of entry to the 
human body.  
 
Various inhalation delivery devices have been designed and patented in allopathic medicine, 
including metered dose inhalers, dry powder inhalers, nasal sprays and nebulizers. Novel 
respiratory drug delivery systems are indeed topical at the moment and the intra-nasal route, 
for example, has also been successfully exploited in the systemic delivery of many drugs. 
Miacalcic Nasal Spray 200IU produced and patented by Novartis is one such ideal delivery 
system to administer the hormone Calcitonin to the body through the respiratory system. This 
nasal spray has shown success in the reduction of new vertebral fractures in post-menopausal 
osteoporosis patients, which provides further evidence of the value of the respiratory system 
in effective drug delivery to the body. 
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Not only could traditional methods shed light on improved means of administering inhalation 
as an invaluable form of therapy, but could open up avenues for the development of antibiotic 
inhalant devices that could further exploit the efficacy of inhalation as a mode of treatment in 
the medical field.   
 
Previous studies have investigated the antimicrobial activity of essential oil vapour obtained 
from aromatic plants (Inouye et al., 2001). This study will for the first time investigate the 
antimicrobial activity and comparative chemistries of the smoke-derived fractions from 
ethnomedicinally selected plants.  
 
Using two sources (Hutchings, 1996; van Wyk et al., 1997) a comprehensive literature 
review of South African medicinal plants revealed 34 plants that are burnt and the smoke 
inhaled (Table 1.1). This investigation focused on five such plants, namely: Heteropyxis 
natalensis, Myrothamnus flabellifolius, Artemisia afra, Tarchonanthus camphoratus and 
Pellaea calomelanos (bold text in Table 1.1). 
 
Table 1.1: Medicinal plants traditionally administered by inhalation (Hutchings, 1996; van 
Wyk et al., 1997) 
 Species / Family Plant 
part used 
Treatment 
1 Acalypha sp. 
(Euphorbiaceae) 
Twigs Headaches. 
2 Alepidea amatymbica 
(Apiaceae) 
Rhizomes and roots Colds, asthma, chest ailments, influenza, 
abdominal complaints. Smoke inhaled to 
induce mild sedation. 
3 Anemone caffra 
(Ranunculaceae) 
Roots Smoke from smouldering roots inhaled to 
treat colds and headaches. 
4 Ansellia africana 
(Orchidaceae) 
Roots Smoke from burning roots inhaled by the 
Zulu as an antidote to bad dreams. 
5 Artemisia afra  
(Asteracaea) 
Leaves and sometimes 
roots 
Colds, influenza, headache, earache, 
malaria. 
6 Becium grandiflorum 
(Lamiaceae) 
Leaves Smoke inhaled to treat chest pains. 
7 Bridelia cathartica 
( Euphorbiaceae) 
Roots Headaches, menorrhagia, sterility in men. 
Inhaled to treat epilepsy. 
8 Clausena anisata  
(Rutaceae) 
Wood and leaves New-born babies held in the smoke to 
strengthen and clear the lungs and 
strengthen the heart. 
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 Species / Family Plant 
part used 
Treatment 
9 Clematis brachiata 
(Ranunculaceae) 
Leaves In Botswana, smoke inhaled for blood 
problems associated with itchy sores. 
10 Croton gratissimus 
(Euphorbiaceae) 
Roots, leaves Coughs, abdominal pains, and used as 
protective charms. 
11 Dombeya rotundifolia 
(Sterculiaceae) 
Bark and sometimes 
the roots and wood 
Chest complaints, nausea in pregnant 
women. Powdered root burnt and smoke 
inhaled. 
12 Euphorbia ingens 
(Euphorbiaceae) 
The latex Asthma, bronchitis. 
13 Gnidia anthylloides 
(Thymelaeaceae) 
Plants Burning plants inhaled to treat fevers and 
bad dreams. 
14 Helichrysum nudifolium 
(Asteraceae) 
Leaves Headaches. 
15 Helichrysum odoratissimum 
(Asteraceae) 
The whole plants Inhaled as protective cleansers and to treat 
coughs and colds. 
16 Helichrysum species 
(Asteraceae) 
Leaves, twigs, 
sometimes the roots 
Coughs, colds, fever, infections, headache, 
menstrual pain. Smoke from burning leaves 
inhaled for pain relief. 
17 Heteromorpha arborescens 
(Apiaceae) 
Roots and sometimes 
stem, bark and leaves 
Headaches, abdominal pains, colic, fever, 
dyspnoea, asthma, coughs, illness and 
mental disorders. Inhaled smoke from 
burning plant to treat headaches. 
18 Heteropyxis natalensis 
(Myrtaceae) 
Leaves, sometimes the 
roots 
Treatment of colds. 
19 Knowltonia anemonoides 
(Ranunculaceae) 
Leaves Smoke inhaled to treat headaches. 
20 Knowltonia vesicatoria 
(Ranunculaceae) 
Fresh leaves, 
sometimes the roots 
Headaches, rheumatism, colds, influenza. 
Smoke from burning leaves inhaled for 
relief of headaches. 
21 Lippia javanica 
(Verbenaceae) 
Leaf infusions are 
inhaled 
Coughs, colds. 
22 Myrothamnus flabellifolius 
(Myrothamnaceae) 
Leaves, twigs, rarely 
the roots 
Chest pains and asthma, respiratory 
ailments. Smoke from burning leaves 
inhaled. 
23 Ocotea bullata  
(Lauraceae) 
Stem bark Ground bark inhaled to treat headaches. 
Also used for gastro-intestinal complaints, 
and as an emetic for nervous and emotional 
disorders. 
24 Oxygonum dregeanum Fruit Smoke from burning fruit inhaled to stop 
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 Species / Family Plant 
part used 
Treatment 
(Polygonaceae) nosebleeds. 
25 Pellaea calomelanos 
(Adiantaceae) 
Leaves and rhizomes Chest and head colds, asthma. Other fern 
species also inhaled. 
26 Protasparagus laricinus 
(Asparagaceae) 
The whole plant Gynaecological problems. Smoke from 
burning plants used by the Tswana and 
Kwena for ‘diseases of women’. 
27 Ranunculus multifidus 
(Ranunculaceae) 
The whole plants Sotho inhale smoke from burning plants to 
treat headaches. 
28 Salvadora australis 
(Salvadoraceae) 
Leaves Inhaled smoke is used to stop nosebleeds. 
29 Schotia brachypetala 
(Caesalpinaceae) 
Leaves Nosebleeds. 
30 Solanum aculeatissimum 
(Solanaceae) 
Fruit Smoke from burning fruit used to treat 
toothache. 
31 Sutera sp. 
(Scrophulariaceae) 
The whole plants Smoke inhaled to treat mental patients. 
32 Tarchonanthus 
camphoratus  
(Asteraceae) 
Leaves and twigs Inhaled smoke from burning crushed leaves 
and branches used for treating asthma, 
headache and rheumatism. 
33 Veronia natalensis 
(Asteraceae) 
The whole plants Smoke inhaled to treat headaches. 
34 
 
Ximenia caffra  
(Olacaceae) 
Roots Smoke from powdered burning roots 
inhaled by the Vhavenda to cease bleeding 
from the nose and mouth. 
 
 
1.1 Heteropyxis natalensis (Myrtaceae) 
Common names: Lavender tree (English), Laventelboom (Afrikaans), Inkunzi (Zulu) 
 
1.1.1. Botanical description: Described as a small tree of not more than 10 metres in height 
(Palmer and Pitman, 1972; Coates Palgrave, 1977) consisting of a branched trunk, dense 
leafy branches and highly aromatic foliage. The bark has a distinctly mottled appearance and 
the leaves are simple, oblong and shiny green at maturity (van Wyk et al., 1997). The small 
yellow flowers are inconspicuous and are followed by tiny dry capsules (van Wyk et al., 
1997). The blossoms and ground leaves have a strong odour of lavender and thus H. 
natalensis is named the “lavender tree” (Palmer and Pitman, 1972). 
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Figure 1.1: Leaves and buds of      Figure 1.2: Geographical distribution of                   
H. natalensis.                                H. natalensis in South Africa.  
 
1.1.2. Distribution: Common in the north-eastern parts of South Africa (van Wyk et al., 
1997). 
 
1.1.3. Medicinal uses and preparations: Infusions of the leaves are mainly used to treat colds, 
but root decoctions have also been used to treat menorrhagia (Hutchings, 1996; van Wyk et 
al., 1997). Powdered leaves form part of a traditional veterinary medicine, and a medicinal 
tea may be made from the leaves (Watt and Breyer-Brandwijk, 1962). 
 
1.1.4. Previous work: The essential oil of the plant is highly aromatic and previous studies 
have shown antimicrobial activity against bacteria and fungi (Gundidza et al., 1993). The 
essential oil contains a wide range of monoterpenoids, mainly, 1,8-cineole, limonene, 
linalool, myrcene, and β-ocimene (Gundidza et al., 1993; Weyerstahl et al., 1992). According 
to van Wyk et al. (1997) the chemical basis for the reported haemostatic effect is not known. 
 
1.2 Myrothamnus flabellifolius (Myrothamnaceae) 
Common names: Resurrection plant (English), Bergboegoe (Afrikaans), Uvukwabafile (Zulu) 
 
1.2.1. Botanical description: A small woody shrub of not more than 0, 4 meters tall, with 
tough, rigid branches (Weimarck, 1936). The leaves are toothed along their upper edges and 
are fan-shaped (van Wyk et al., 1997). The flowers are inconspicuous and are only borne in 
summer. A remarkable feature of the plant is its ability to transform its seemingly dead and 
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brown leaves to bright green when placed in water, hence its vernacular name: The 
resurrection bush/plant. 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.2. Distribution: Found in the northern parts of South Africa, in exposed rocky places and 
dry mountain slopes (Weimarck, 1936). 
 
1.2.3. Medicinal uses and preparation: Numerous traditional uses have been reported by 
utilising the leaves and twigs of the plant (Hutchings, 1996; van Wyk et al., 1997). 
Myrothamnus flabellifolius is usually taken orally as an infusion or a decoction, or the leaves 
are burnt and smoke inhaled (Hutchings, 1996). Chest pains and asthma have been treated by 
inhaling smoke from burning leaves (Hutchings, 1996; Watt and Breyer-Brandwijk, 1962). 
Infusions are taken orally to treat colds and respiratory ailments (van Wyk et al., 1997). 
Decoctions are used to treat various ailments, including menstrual pain, backache, kidney 
problems, and even haemorrhoids. Topical uses include the treatment of abrasions and using 
the dry and powdered leaves for dressing wounds and burns (van Wyk et al., 1997; von 
Koenen, 1996). 
 
1.2.4. Previous work: According to van Wyk et al. (1997), camphor is the major constituent 
of the oil. There may also be small amounts of α-pinene and 1,8-cineole (van Wyk et al. 
1997). Camphor and other monoterpenoids are known to have decongestant and antiseptic 
effects (Bruneton, 1995), and van Wyk et al. (1997) report that the pain-relieving activity 
must be related to these constituents. Later studies by Viljoen et al. (2002) have identified the 
major compounds in the essential oil to be pinocarvone, trans-pinocarveol, limonene, trans-
p-menth-1-(7)-8-diene-2-ol, and cis-p-menth-1-(7)-8-diene-2-ol. The essential oil exhibited 
Figure 1.3: M. flabellifolius in habitat.                                   Figure 1.4: Geographical distribution of 
                                                                        M. flabellifolius in South Africa.  
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antibacterial and antifungal activity against nine out of eleven pathogens tested in a previous 
study by Viljoen et al. (2002). 
 
1.3 Artemisia afra (Asteracaea) 
Common names: African Wormwood (English), Wildeals (Afrikaans), Umhlonyane (Zulu, 
Xhosa), Lengana (Sotho, Tswana) 
 
1.3.1. Botanical description: An aromatic, erect, multi-stemmed, perennial shrub of not more 
than two metres in height. The small flowers are yellow and situated along the branch ends. 
The leaves are greyish-green in colour, finely divided, and feathery in texture (van Wyk et 
al., 1997). 
 
Figure 1.5: Leaves of A. afra.                                 Figure 1.6: Geographical distribution of A.
               afra in South Africa.  
1.3.2. Distribution: A very common species in South Africa and is naturally distributed 
northwards towards tropical east Africa as far as Ethiopia (van Wyk et al., 1997). 
 
1.3.3. Medicinal uses and preparation: Artemisia afra is one of the most widely used 
traditional medicines in South Africa (van Wyk et al., 1997). Various illnesses are treated 
with this plant - mainly, colds, coughs and influenza (Rood, 1994; Watt and Breyer-
Brandwijk, 1962; Dykman, 1891). Other symptoms and conditions reported to be treated with 
Artemisia afra are colic, fever, headache, earache, loss of appetite, intestinal helminthes, and 
malaria (Hutchings and van Staden, 1994; Watt and Breyer-Brandwijk, 1962). The leaves and 
sometimes the roots are used to make an infusion or a decoction that is sweetened to mask the 
bitter taste (Rood, 1994). It is also not uncommon for the leaves to be boiled and the fumes 
inhaled for therapeutic purposes (Bhat and Jacobs, 1995). The aerial parts of the plant are 
concentrated in essential oils and are often used as an inhalant (Bhat and Jacobs, 1995). 
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1.3.4. Previous work:  Preliminary tests revealed analgesic, narcotic and antihistaminic 
activities of this plant (Hutchings, 1989). Work by Graven et al., (1992) confirmed the 
antimicrobial and anti-oxidative properties of the volatile oil of Artemisia afra. Bruneton 
(1995) confirmed the decongestant and antibacterial effects of the oils of Artemisia afra. The 
oil contains 1,8-cineole, β-thujone, α-thujone, borneol, and camphor (Graven et al., 1992). 
Other constituents include terpenoids of the eudesmadien and germacrene types and 
coumarins and acetylenes, all of which have no known contribution to the biological activity 
of the plant. Antimicrobial activity of A. afra was reported in previous studies by Graven et 
al. (1992), and this was later validated by time-kill studies of the essential oil using the 
respiratory pathogens Cryptococcus neoformans and Klebsiella pneumoniae (Viljoen et al., 
2006).  
 
1.4 Tarchonanthus camphoratus (Asteraceae) 
Common names: Wild camphor bush (English), Vaalbos (Afrikaans), igqeba-elimhlophe, 
siduli-sehlathi (Zulu), Mathola (Xhosa), Mohata (Tswana) 
 
1.4.1. Botanical description: A small tree or shrub of up to six meters tall with a greyish 
appearance (van Wyk et al., 1997). The oblong leaves have a dark green and net-veined upper 
surface, and pale grey and velvety lower surfaces. The plant is adorned with small whitish 
flower heads and tiny woolly fruits (Palmer and Pitman, 1972). 
 
 
 
 
 
 
 Figure 1.7: Leaves of T. camphoratus.  
 
Figure 1.8: Geographical distribution of  
T. camphoratus in South Africa.  
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1.4.2. Distribution: Found in a wide variety of habitats in almost any part of South Africa 
(Coates Palgrave, 1977).  
 
1.4.3. Medicinal uses and preparation: Fresh or dried plant leaves and branches are crushed 
and burnt and smoke is inhaled for asthma, rheumatism, and headaches. (Watt and Breyer-
Brandwijk, 1962; Hutchings and van Staden, 1994). According to Watt and Breyer-
Brandwijk (1962), the Koi and San smoke the dry leaves in the way tobacco is smoked and 
experience a type of narcotic effect. Van Wyk et al. (1997) reported the use of a hot poultice 
for treating bronchitis and inflammation, in addition to headaches and asthma. Leaves and 
twigs have also been used to prepare infusions and tinctures that are either taken orally or 
chewed to produce an effect. Infusions and tinctures are used traditionally to treat abdominal 
complaints, headaches, toothache, asthma, bronchitis and inflammation (van Wyk et al., 
1997; Hutchings and van Staden, 1994). 
 
1.4.4. Previous work:  The volatile oil has a characteristic camphor-like aroma and is the part 
of the plant said to be responsible for the reported analgesic, decongestant, diaphoretic and 
analgesic effects (Bruneton, 1995). The plant actually contains only small amounts of 
camphor, with flavonoids and other constituents of the volatile oil being far more abundant 
(van Wyk et al., 1997). Major active ingredients include α-fenchyl alcohol, 1,8-cineole, α-
terpineol, and pinocembrin (van Wyk et al., 1997). 
 
1.5 Pellaea calomelanos (Adiantaceae) 
Common names: Hard fern (English), Inkomankomo (Zulu), Iehorometso (Sotho) 
 
1.5.1. Botanical description: Described in van Wyk et al. (1997) as a common and distinctive 
fern with an underground rootstock covered in small brown scales and about 6 mm in 
diameter. The tiny leaflets are blue-green in colour and triangular in shape, and join together 
to form large firm-textured leaves (Schelpe and Anthony, 1986; Jacobson, 1983). The leaves 
bear a distinct line of brown spore-producing bodies (sori) along their edges (Schelpe and 
Anthony, 1986).  
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1.5.2. Distribution: Is distributed widely across southern Africa, can withstand seasonal 
droughts and is therefore found even in extremely dry places (van Wyk et al., 1997; 
Jacobson, 1983). 
 
1.5.3. Medicinal uses and preparations: The leaves are burnt and the smoke is inhaled to treat 
chest colds, head colds, and asthma (Watt and Breyer-Brandwijk, 1962; van Wyk et al., 
1997; Hutchings and van Staden, 1994). An early Cape remedy was a tea made from this 
species that was used to treat chest complaints and colds (van Wyk et al., 1997). Decoctions 
have also been prepared from the rhizomes and applied externally to heal boils and abscesses 
and are taken internally to remedy intestinal parasites (van Wyk et al., 1997). 
 
1.5.4. Previous work: Very little has been reported on the chemistry of Pellaea species 
(Dictionary of Natural Products on CD-ROM, release 4:2, Chapman & Hall, London, 1996). 
Many ferns do, however, contain triterpenoids of the hopane type such as adiantone, as well 
as a number of flavonoids. No relationship has been found between the chemistry of any fern 
leaves, including those of Pellaea calomelanos, and their therapeutic uses, but van Wyk et al. 
(1997) postulate that triterpenoid saponins play a role. It is worth noting that a few saponin-
containing medications have known potential as anti-inflammatory and analgesic agents 
(Bruneton, 1995). 
 
 
 
Figure 1.9: P. calomelanos in habitat.                 Figure 1.10: Geographical distribution of  
                                      P. calomelanos.     
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Study objectives: 
 
• To simulate the burning process employed traditionally during inhalation therapy with 
selected plant species and to capture the volatile (smoke) fraction for analysis and 
biological testing; 
• To determine and compare the antimicrobial activity of the inhalation extracts and 
conventionally prepared solvent extracts; 
• To compare the chromatographic profiles of the solvent extracts to the smoke fraction; 
and 
• To provide insight into inhalation therapy and emphasise the benefits of inhalation as 
a common mode of administration in traditional healing.  
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1. Preparation of samples for combustion experiment 
 
Fresh plant material was collected from local sites and allowed to air dry. The selected plant 
parts, i.e. roots, stems, leaves, rhizomes and twigs, were prepared by cutting, grinding, and 
crushing the plant material. A standard dry weight of 20g of plant material was used in each 
of the combustion experiments.  
 
Table 2.1: The origin and voucher details for plants used in this study. 
Species/ Family Locality Voucher Plant part used 
Heteropyxis natalensis 
(Myrtaceae) 
Johannesburg 
Botanical Gardens 
SVV 954 Leaves 
Artemisia afra  
(Asteracaea) 
Klipriviersberg SVV 935 Leaves  
Myrothamnus flabellifolius 
(Myrothamnaceae) 
Klipriviersberg SVV 934 Leaves and twigs 
Pellaea calomelanos 
(Adiantaceae) 
Walter Sisulu 
Botanical Garden 
AV 1280 Aerial parts 
Tarchonanthus camphoratus 
(Asteraceae) 
Walter Sisulu 
Botanical Garden 
SVV 961 Leaves  
 
The combustion apparatus depicted below (Figure 2.1) consisted of a modified pressure-
cooker with an entry pipe and an exit pipe, a heating plate (maintained at 150°C), a condenser 
surrounding the exit pipe, a water bath, a round-bottomed flask, and a cryostat. Plant material 
(20g) was carefully placed in a foil dish and inserted into the pot and allowed to burn to 
produce smoke. A pump attached to the entry pipe maintained a positive pressure which 
directed the smoke through the tubing exit pipe and into a round-bottomed flask containing 
solvent. A mixture of a polar and a non-polar solvent was used in order to capture polar and 
non-polar compounds from the smoke fraction. The solvent was a 1:1 mixture of hexane and 
methanol (250ml). 
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Figure 2.1: The combustion apparatus used in this study to mimic the inhalation process used 
in a traditional setting. 
 
The plant material was burnt for a standard time of 30 minutes to simulate the average time a 
patient would be exposed to the therapy by a traditional healer. The smoke bubbled into the 
hexane-methanol mixture in the bottom of the flask. The round-bottomed flask was placed in 
a water bath containing water and polyethylene-glycol (anti-freeze). The water-polyethylene-
glycol mixture was pumped through the water bath in which the round-bottomed flask was 
placed and also through the jacket of the condenser. The water bath-condenser-cryostat 
circuit cooled down the round-bottomed flask and minimised evaporation of the smoke 
fraction. The cryostat effectively maintained the water bath temperature at -8 °C. 
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Figure 2.2:  Smoke captured in hexane-methanol.  Figure 2.3: Concentrating the smoke 
fraction. 
 
After 30 minutes the hexane-methanol smoke fraction was concentrated using a rotavap. The 
inhalation samples/extracts were then removed from the rotavap and left to dry in a fume 
hood in order to produce dry extracts for analysis and microbiological testing.  
 
2.2. Preparation of solvent (methanol and acetone) and aqueous extracts 
 
Dried plant material (2.0g) was finely cut, ground, and extracted with 50ml of each solvent 
(water, methanol, and acetone). The plant extracts were macerated, extracted overnight, then 
filtered and allowed to dry in a fume hood and oven (at 40°C). Water extracts were freeze 
dried to accelerate the drying process. The residues were reconstituted with their respective 
solvents by adding 1ml of solvent. Essential oil samples of all of the selected plants with the 
exception of Pellaea calomelanos (which is not aromatic) were made available from previous 
studies.  
 
2.3. Antimicrobial assays / minimum inhibitory concentration (MIC) 
 
The minimum inhibitory concentration (MIC) is the lowest concentration that prevents 
visible growth of an organism after incubation in a specified growth medium and was used to 
quantitatively measure the in vitro antimicrobial activity of test extracts before and after 
burning (Dipiro et al., 2002; van Vuuren, 2003). In this study, the MIC was determined by 
using the p-iodonitrotetrazolium violet (INT) microplate bioassay technique (Eloff, 1998a).   
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Antimicrobial assays were performed on the 24 samples, with the plant samples being tested 
against four micro-organisms. The prepared plant extracts were tested for activity against 
Staphylococcus aureus (ATCC 25923), Bacillus cereus (ATCC 11778), Klebsiella 
pneumoniae (ATCC 9633), and Cryptococcus neoformans (ATCC 90112). MICs were 
performed at least in duplicate and in some instances, triplicate where MIC values were not 
congruent between repetitions.  
 
The MIC microtitre plate method was employed, containing a standard inoculum of bacteria 
(1-5 x 105 colony forming units), liquid growth media and doubling serial dilutions of the 
antimicrobial substance of interest (inhalation extracts and laboratory extracts). The 
microtitre plates were then prepared aseptically by placing 100µl sterile water in all wells. 
100µl of each sample/extract to be tested was placed in Row A, so that wells A1-AH 
contained 100µl of each sample. Serial dilutions were then carried out from wells A through 
to H. For example, 100µl of contents from well A1 was withdrawn (after its contents had 
been thoroughly mixed) and transferred to well B1. This procedure was then repeated from 
well C1 onwards to well H1, diluting by 100µl each time. The 100µl withdrawn from well 
H1 was discarded. Then 100µl of the specific cultured respiratory pathogen was added to all 
the wells. The plates were then incubated for 24 hours (bacterial pathogens) and for 48 hours 
(Cryptococcus neoformans) at a temperature of 37οC.  
 
After incubation of the plates, 40µl of 0.02 mg/ml p-iodonitrotetrazolium violet (INT) 
solution was prepared and added to each well. Plates were then viewed after six hours and 
yeast plates were viewed after 24 hours. INT was used to indicate biological activity and 
showed a colour change in relation to the concentration of microbial growth. The first 
colourless well in a row of decreasing concentrations of a given extract is the MIC of that 
specific sample (Eloff, 1998a). 
 
Positive and negative controls were included in the assay. The positive controls consisted of 
wells containing commercially used antibiotics, either ciprofloxacin (for bacteria) or 
amphotericin B (for the yeast C. neoformans). The positive controls gave an indication of the 
sensitivity of the micro-organisms tested. Negative controls consisted of broths that were 
incubated under the same conditions as the plates so that sterility of the nutrient media was 
ensured. Blank controls (using solvent) were also included to ascertain whether the diluents 
had any inherent activity. Blank controls were carried out for methanol, acetone and water.   
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Figure 2.4: Aseptic preparation of MIC  
plates to record the antimicrobial activity of the extracts. 
Samples
32 mg/ml
0.0625 mg/ml
C
o
n
c
e
ntratio
n
MIC: 2 
mg/ml
 
Figure 2.5: Example of a MIC plate showing the wells after INT was added (the red to pink 
colour indicates microbial growth and the colourless wells indicate no microbial growth due 
to antimicrobial activity of the samples). 
 
2.4. Thin layer chromatography (TLC) 
 
The chromatographic profiles of the extracts were initially examined by thin layer 
chromatography. The five samples obtained from the combustion experiment were spotted 
next to their respective methanol extracts (Figure 3.1).  
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The samples were dissolved in 1ml methanol to yield a concentration of 100 mg/ml of which 
5µl was applied to a silica gel (Merck) TLC plate using a calibrated micro-capillary tube. The 
plates were developed in two mobile phases: 1. toluene:ethyl acetate (93:7), and 2. 
toluene:dioxane:acetic acid (90:25:10) for 10-20 minutes. The plates were visualised under 
UV light (365 and 254nm). The plates were sprayed with vanillin-sulphuric acid (1% 
ethanolic vanillin, 10% ethanolic sulphuric acid) spray reagent, and placed in an oven at 
110°C for five minutes. 
  
2.5. High performance liquid chromatography (HPLC) 
 
The application of HPLC in pharmacognosy is well established and can be used for the 
separation and identification of alkaloids, glycosides, saponins, flavanoids and secondary 
metabolites (Skoog and Leary, 1992). HPLC is also widely used for the separation of 
complex organic and inorganic molecules such as antibiotics, steroids, analgesics, diuretics 
and anti-inflammatory compounds (Skoog and Leary, 1992; Hannah, 2001). 
 
The methanol and acetone extracts and the samples obtained from the combustion experiment 
were analysed by HPLC-UV-MS (because of insufficient samples the water extract was not 
analysed by HPLC). Extracts were weighed and transferred to eppendorffs to which 
calculated concentrations of methanol or acetone was added to yield a final concentration of 
50 mg/ml.  
 
A Waters 2690 HPLC system (equipped with a Phenomenon Aqua C18 column, 250mm x 
2.1mm column) equipped with a 996 photodiode array detector (PDA) and a thermabeam 
mass selective detector (TMD) was used to analyse the samples. The thermabeam generates 
classical electron impact spectra, which can be compared to commercial MS spectra libraries 
like NIST and WILEY. The injection of 10µl was done under the following conditions: flow 
rate was 0.2ml/min, gas flow in the nebulizer was 301/h, the nebulizer temperature was 80°C, 
the expansion region was 90°C, and the source of temperature was 225°C. The mobile phase 
started off with 10% acetonitrile, 90% water containing 100mM formic acid. The solvent 
ratio was changed through a linear gradient to 90% acetonitrile, 10% water and formic acid at 
40 minutes. The ratio was maintained for 10 minutes, and then the solvent ratio was changed 
back to the initial starting conditions. The data was analysed using Empower software.      
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CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1. Chemical comparison of extracts 
 
3.1.1. Thin layer chromatography (TLC) 
 
TLC was used to compare the chromatographic profiles of the various extracts. Figure 3.1 (A 
and B)  shows the TLC profiles of all five inhalation extracts together with the respective 
methanol extracts developed in two different mobile phases. It was observed that the profiles 
of the inhalation sample compared to the methanol extract of the same plant were 
distinctively different. Track 1.2 represents the methanol extract of H. natalensis and shows a 
spot at Rf 0.2 which is absent in the sample produced by the combustion experiment (track 
1.1). Similarly, plate B shows distinct differences between the two samples of Pellaea 
calomelanos (track 4.1 and 4.2).   
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Figure 3.1: Thin layer chromatography performed on the inhalation and methanol extracts 
developed in two mobile phases: A = toluene:ethyl acetate (93:7), B = toluene:dioxane:acetic 
acid (90:25:10) 
Tracks = 1.1. H. natalensis (inhalation), 1.2. H. natalensis (MeOH), 2.1 M. flabellifolius 
(inhalation), 2.2 M. flabellifolius (MeOH), 3.1 A. afra (inhalation), 3.2 A. afra (MeOH), 4.1 
P. calomelanos (inhalation), 4.2 P. calomelanos (MeOH), 5.1 T. camphoratus (inhalation), 
5.2 T. camphoratus (MeOH).  
 
 
 
1.1 1.2 2.1 2.2 3.1 3.2 4.1 4.2 5.1 5.2 
1.1 1.2 2.1 2.2 3.1 3.2 4.1 4.2 5.1 5.2 
A 
B 
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3.1.2. High performance liquid chromatography (HPLC) 
 
Figures 3.2-3.27 represent the HPLC chromatograms of the methanol, acetone, and inhalation 
extracts. The first set of HPLC analyses (HPLC-UV) detected constituents in the extracts that 
have chromophores (absorb light within the UV-spectrum), and the second set of HPLC 
analyses (HPLC-MS) was coupled to mass spectroscopy and detected constituents in the 
extracts that may not have chromophores (do not absorb light in the UV-spectrum). 
 
3.1.2.1. Heteropyxis natalensis 
 
_______ H. natalensis Acetone     
_______ H. natalensis Methanol 
_______ H. natalensis Inhalation 
Figure 3.2:  HPLC-UV chromatograms of the acetone, methanol and inhalation extracts of  
Heteropyxis natalensis. 
 
 The three HPLC-UV profiles for this plant were found to be quite similar, with the same 
compounds observed at retention times 3.53 minutes, 12.37 minutes, 34.92 minutes, and 
36.33 minutes. The same compound is also observed in the methanol and acetone profiles at 
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retention time 12.96 minutes. In contrast, it is interesting to observe how few compounds are 
detected for the inhalation sample as opposed to the methanol and acetone samples over the 
retention times 13-22 minutes (Table 3.1). It is a possibility that the burning process 
destroyed certain constituents. 
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Figure 3.3: HPLC-MS chromatogram of H. natalensis acetone extract. 
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Figure 3.4: HPLC-MS chromatogram of H. natalensis methanol extract. 
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Figure 3.5: HPLC-MS chromatogram of H. natalensis inhalation extract. 
The H. natalensis inhalation extract above (Figure 3.5) showed a dramatically different 
HPLC-MS chromatogram from the acetone and methanol chromatograms of the same plant 
(Figure 3.3 and Figure 3.4 respectively). There is a characteristic peak at retention time 14.82 
minutes and at 45.15 minutes for the inhalation sample. It was also interesting to note that 
there were obvious similarities between the acetone and the methanol profiles above 
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(common compounds occur at retention times 3.91, 4.04, 5.32, 31.91, and 35.02 minutes), 
showing that the two solvents may extract with similar efficiency. The inhalation sample 
contained certain compounds also found in the conventional solvent extracts (compound at 
retention time 34.69 minutes is common to all three HPLC-MS profiles above).   
 
3.1.2.2. Myrothamnus flabellifolius 
 
_______  M. flabellifolius Acetone     
_______  M. flabellifolius Methanol 
_______  M. flabellifolius Inhalation 
Figure 3.6:  HPLC-UV chromatograms of the acetone, methanol and inhalation extracts of 
Myrothamnus flabellifolius. 
The acetone and methanol extracts have similar HPLC-UV profiles, but the inhalation 
extract differs. The same large peak is seen in the methanol and acetone profiles at 
retention time 14.40 minutes and another compound is also common at retention time 
21.44 minutes (Table 3.1). The grouping of characteristic ‘polar’ peaks early on in the 
inhalation sample chromatogram and again the lack of substantial peaks from 
retention time 13 minutes onwards was worth noting. The same two compounds are 
seen in all three profiles at retention times 4.67 minutes and 5.59 minutes (confirmed 
by UV data). However, the inhalation sample has peaks at 3.06 minutes and 9.72 
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minutes that are not present in the methanol and acetone extracts of the same plant 
(Table 3.1).  
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Figure 3.7: HPLC-MS chromatogram of M. flabellifolius acetone extract.  
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Figure3.8: HPLC-MS chromatogram of M. flabellifolius methanol extract. 
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Figure 3.9: HPLC-MS chromatogram of M. flabellifolius inhalation extract. 
The comparison of M. flabellifolius HPLC-MS chromatograms above again revealed 
comparable chromatograms between the conventional methanol and acetone extracts. The 
chromatogram of the inhalation extract is distinctively different from the chromatograms of 
the acetone and methanol extracts. Evident is the abundance of late eluting peaks in the 
inhalation chromatogram, which is absent in the other two analysed samples between 
retention times 46.05-52.43 minutes. In summary, the M. flabellifolius inhalation 
chromatogram showed characteristic UV absorbance peaks early on in the UV profile (Figure 
3.6) and characteristic compounds eluting late in the HPLC-MS profile (Figure 3.9).  
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3.1.2.3. Artemisia afra 
  
 
_______  A. afra Acetone     
_______  A. afra Methanol 
_______  A. afra Inhalation 
Figure 3.10:  HPLC-UV chromatograms of the acetone, methanol and inhalation extracts of 
Artemisia afra. 
 
Evident above is the presence of the same peak in all three extracts of A. afra at retention 
time 13.41 minutes (Table 3.1). Another compound is common to all three profiles at 
retention time 32.86 minutes (Table 3.1). It is also important to point out certain similarities 
in the profiles of the methanol and acetone profiles with the same peaks observed at retention 
times 21.13 minutes, 23.39 minutes, 28.18 minutes and 28.87 minutes (Table 3.1). There is 
also a marked dissimilarity between the acetone and the methanol extracts, with an 
abundance of peaks occurring late on in the acetone profile between retention times 25 
minutes to 35 minutes (Table 3.1).  
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The HPLC-UV chromatogram of the inhalation sample, above, shows a few major peaks 
early on in the profile (at 3-6 minutes) that are not present in the acetone and methanol 
extracts (Table 3.1). Worth noting is the major peak in the inhalation sample at retention time 
5.46 minutes with an integration area of 34.18%. This compound is absent in the methanol 
and acetone samples (Table 3.1).  
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Figure 3.11: HPLC-MS chromatogram of A. afra acetone extract. 
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Figure 3.12: HPLC-MS chromatogram of A. afra methanol extract. 
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Figure 3.13: HPLC-MS chromatogram of A. afra inhalation extract. 
 
In the A. afra HPLC-MS chromatograms the compounds present in the acetone and methanol 
samples are not as prominent in the inhalation extract, perhaps because of destruction during 
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combustion. There were distinct commonalities between the acetone and methanol extracts of 
A. afra. There were also a number of distinctive peaks late on in the inhalation chromatogram 
that was unique to the A. afra inhalation sample at retention times 35.98 to 52.77 minutes 
(Figure 3.13). The late peaks seen in Figure 3.13 and the distinctive early peaks seen in 
Figure 3.10 for the inhalation extract may elude to the differences observed in the 
microbiological results.  
 
3.1.2.4. Pellaea calomelanos 
 
_______  P. calomelanos Methanol     
_______  P. calomelanos Inhalation 
_______  P. calomelanos Acetone 
 
Figure 3.14:  HPLC-UV chromatograms of the acetone, methanol and inhalation extracts of 
Pellaea calomelanos. 
 
It is clear that the three profiles are very different. A major peak is evident in the inhalation 
extract at 9.62 minutes that is not seen in the methanol and acetone extracts (Table 3.1). This 
is a major peak with an integration area of 31.86%. This chemical difference occurs alongside 
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marked antimicrobial superiority of the P. calomelanos inhalation extract when tested against 
S. aureus and B. cereus (Table 3.2). It should also be mentioned at this point that it was the P. 
calomelanos inhalation extract that demonstrated greater antimicrobial activity than all 
solvent extracts and against all pathogens tested (Table 3.2).  Another unique peak in the 
inhalation chromatogram occurs at retention time 14.08 minutes.  Noticeable too is the cluster 
of late eluting peaks in the acetone extract (retention times: 39-51 minutes) which are absent 
in both the inhalation and the methanol profiles. 
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Figure 3.15: HPLC-MS chromatogram of P. calomelanos acetone extract. 
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Figure 3.16: HPLC-MS chromatogram of P. calomelanos methanol extract. 
In
te
n
si
ty
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00
 
Minutes 
Figure 3.17: HPLC-MS chromatogram of P. calomelanos inhalation extract. 
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The chromatograms of the acetone and inhalation extracts of Pellaea calomelanos are alike 
and seem to contain similar constituents.  
 
 
3.1.2.5. Tarchonanthus camphoratus  
 
 
_______  T. camphoratus Acetone     
_______  T. camphoratus Methanol 
_______  T. camphoratus Inhalation 
Figure 3.18:  HPLC-UV chromatograms of the acetone, methanol and inhalation extracts of 
Tarchonanthus camphoratus.  
 
The HPLC-UV chromatogram of the inhalation extract is different from the acetone and 
methanol profiles. A number of significant peaks are evident at the beginning of the 
inhalation chromatogram that are not present in the other profiles. The characteristic peak at 
5.59 minutes for the inhalation sample has an integration area of 39.97%.  The same 
compounds are evident in the methanol and acetone extracts at retention times 21.04 minutes 
and 30.41 minutes (Table 3.1). The same compounds are seen in all three profiles at retention 
times 31.16 minutes and 35.83 minutes (Table 3.1).  
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Figure 3.19: HPLC-MS chromatogram of T. camphoratus acetone extract. 
In
te
ns
ity
0.00
1.00
2.00
3.00
4.00
5.00
6.00
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00
 
Minutes 
Figure 3.20: HPLC-MS chromatogram of T. camphoratus methanol extract. 
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Figure 3.21: HPLC-MS chromatogram of T. camphoratus inhalation extract. 
The T. camphoratus HPLC-MS chromatograms significantly supported the hypothesis of this 
study. The HPLC-MS chromatogram of the inhalation extracts shows several constituents not 
seen in the methanol and acetone extracts of the same plant. The T. camphoratus inhalation 
extract had unique compounds at retention times: 46.03, 46.05, 47.24, 47.31, 48.91, 48.96, 
and 52.43 minutes that did not occur in the methanol and acetone extracts of the same plant 
(Figures 3.19 and 3.20).  
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
2.98 
            7.54%   
3.06 
   2.48%            
3.07 
         5.22%      
3.27 
      24.15%         
3.53 11.67% 6.85% 4.65%             
3.67 
            11.68% 3.51%  
3.69 
         10.43%      
3.70 
      8.02%         
3.73 
          0.78%     
3.76 
     2.13%          
3.79 
   3.21%            
3.84 
 2.79%              
3.92 4.50%               
3.99 
           7.09%    
4.02 
          6.37%     
4.07 
  2.06%  2.66%  10.34% 5.61%        
4.08 
            15.04%   
4.09 
             10.63%  
4.10 1.29%        5.71% 6.09%     2.70% 
4.13 
     4.38%          
4.16 
 4.74%              
4.18 
   8.27%            
4.59 
         0.44%      
4.63 
            1.41%   
4.65 
 1.89%              
4.67 
   1.13% 2.85% 6.09% 2.79%         
4.87 
            7.02%   
4.88 
           2.68%    
4.92 
  2.62%             
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
4.96 
          0.88%     
4.99 
   2.93%            
5.01 
      7.06%         
5.37 14.83%               
5.46 
      34.18%         
5.52 
     17.44%          
5.55 
 9.58%              
5.59 
   26.31% 13.58% 7.51%    20.08%   39.57%   
6.13 
    1.33%           
6.54 
    1.19%           
7.14 
            1.30%   
7.28 
   1.69%            
7.74 2.54%               
8.11 
         2.23%      
9.05 21.79%               
9.62 
         31.86%      
9.72 
   43.15%            
9.93 
            8.90%   
10.01 
 22.50%    36.04%          
11.39 
       0.51%        
11.41 
     1.19%          
11.54 11.84%               
11.55 
    11.06%           
11.69 
          1.44%     
11.70 
             2.53%  
12.08 5.10%   0.67%   1.89%   3.52%   0.999%   
12.20 
          0.78%     
12.23 
         3.98%      
12.25 
   2.43% 0.21%           
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
12.28 
      0.85%         
12.37 8.56% 1.60% 11.52%             
12.47 
    0.52%           
12.70 
            0.26%   
12.77 
 2.75%    0.47%          
12.82 
    1.05%           
12.96 
 7.92% 14.77%             
13.02 
      0.49%         
13.11 
          4.99% 4.01%    
13.29 
 2.23% 1.61%     11.40%      7.82%  
13.41 
      1.25% 11.06% 2.45%  4.68%     
13.69 
          3.09%     
13.74 
    0.53%           
13.83 
       0.65%        
13.89 
 3.50% 1.05%  0.78%           
13.93 
          1.71%     
14.06 
       0.70%        
14.08 
         11.00%      
14.17 
 2.09% 5.27%             
14.40 
    10.18% 12.25%          
14.42 
          2.46%     
14.69 
 3.08% 5.53%             
14.97 
          0.58%     
15.46 
               
15.50 
    1.07%           
15.75 
          0.77%     
16.04 
     2.52%          
16.07 
  2.56%             
16.10 
    4.54%           
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
16.33 
       1.34%        
16.56 
          1.41%     
16.67 
    1.46%           
16.79 
          0.77%     
16.83 
  1.91%             
17.18 
 2.18% 4.84%             
17.29 
          2.71%     
17.89 
       1.22%        
17.92 
          15.46% 10.16%    
17.95 0.81%               
18.06 
      0.66%         
18.75 
            0.60%   
18.81 
 5.13%              
18.89 
   0.82% 8.42% 1.90%    0.90%      
18.95 
  10.22%             
19.22 
     1.70%          
19.24 
 2.29%              
19.30 
    6.42%           
19.41 
  2.56%             
19.78 
          14.98%     
19.99 
       1.86%        
20.40 
         1.75% 3.58% 1.29%    
20.45 
       1.00%        
20.54 
      0.94%         
20.56 
  8.38%             
20.63 
             1.17%  
20.67 
       3.44%        
20.69 
          5.43%     
20.81 
 2.89%              
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
20.82 
    0.45%           
20.83 
        2.46%       
20.89 
  4.52%             
21.04 
             13.01% 2.18% 
21.08 
          1.36%     
21.13 
       35.56% 11.97%       
21.16 
             29.38%  
21.31 
 1.09%              
21.44 
    7.64% 2.82%          
21.48 
          0.44%     
21.58 
       1.01%        
21.65 1.02%               
21.95 
               
21.97 
       9.25% 2.54%     2.06%  
22.08 2.84%               
22.11 
    1.89%           
22.41 
          7.04% 0.95%    
22.88 
          4.13% 0.50%    
23.39 
       0.39% 1.54%       
23.61 
       0.98%        
24.09 
      2.26%         
24.76 
          1.19%     
26.99 
              0.96% 
27.00 2.77%               
27.80 
             2.60%  
27.84 
        3.76%       
27.86 
 1.51%              
28.18 
       1.72% 6.33%       
28.87 
       0.93% 3.57%       
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
29.71 
        1.28%       
30.21 
             1.48%  
30.23 
              1.42% 
30.41 
             1.93% 30.407% 
30.83 
 1.20%              
31.16 
            1.13% 4.05% 8.85% 
31.56 
               
31.61 
              0.76% 
31.73 0.61%               
31.93 
              39.03% 
32.32 
           22.02%    
32.33 3.06%               
32.59 
       2.13% 3.95%       
32.67 1.47%               
32.86 
      4.46% 0.88% 2.62%  0.95%  0.44%  0.88% 
32.95 
    0.97%           
33.05 
        2.76%       
33.22 0.56%               
33.85 
 2.38% 1.86%             
33.95 1.57%               
34.09 3.41%               
34.16 
           5.87%    
34.24 
        11.84%       
34.59 0.32%  1.15%             
34.62 
          0.91%     
34.64 
      1.92%         
34.92 6.25% 8.17% 4.96%             
35.03 
             0.61% 19.48% 
35.46 
        3.78%       
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Table 3.1: Summary of HPLC-UV data: Showing the integration (%) for the most prominent peaks in the chromatograms. (derived from Figures 3.2 – 3.21). 
Retention  H. natalensis   M. flabellifolius   A. afra   P. calomelanos   T. camphoratus  
Time (mins) Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone Inhalation Methanol Acetone 
35.53 0.28%               
35.73 0.31%               
35.83 
            3.17% 1.21% 1.54% 
36.33 1.32% 1.35% 1.27%             
36.87 
            0.40%   
36.88 
   0.35%            
36.92 0.51%               
36.93 
              0.30% 
37.47 0.78%               
38.62 1.93%               
39.91 
           2.75%    
39.92 0.32%               
41.55 
           0.26%    
42.14 0.99%               
42.67 1.57%               
43.16 
           5.28%    
43.63 
           12.42%    
43.77 
 2.19%              
43.83 
           1.60%    
44.14 
           5.90%    
45.06 
          1.11%     
46.07 
           7.09%    
46.35 
           2.79%    
49.10 
           2.87%    
52.71 
 1.93%              
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3.1.3. HPLC-UV and HPLC-MS comparison of the five inhalation extracts 
 
The chromatographic profiles of the five inhalation extracts were compared. This was done to 
ascertain whether or not combustion produced the same or similar compounds regardless of 
the particular plant burnt.  
 
_______  M. flabellifolius Inhalation 
_______  A. afra Inhalation 
_______  P. calomelanos Inhalation 
_______  T. camphoratus Inhalation 
_______  H. natalensis Inhalation 
 
Figure 3.22:  HPLC-UV chromatograms of all five inhalation samples i.e. Myrothamnus 
flabellifolius, Artemisia afra, Pellaea calomelanos, Tarchonanthus camphoratus, 
and Heteropyxis natalensis. 
 
The HPLC-UV inhalation chromatograms (Figure 3.22) illustrate that although similar 
compounds do form during combustion of all five plants, their profiles are still significantly 
different and additional compounds are formed that are unique to each species studied. It is 
interesting to note that the P. calomelanos inhalation extract has a major peak at a retention 
time of 14.083 minutes which is absent in all other profiles (Figure 3.22 and Table 3.1). It 
should also be mentioned at this point that it was the P. calomelanos inhalation extract that 
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demonstrated greater antimicrobial activity than all of its solvent extracts against all 
pathogens tested (Table 3.2). A common compound is noted for the H. natalensis and M. 
flabellifolius inhalation extract at retention time 5.37 minutes (Table 3.1). A common 
compound is also seen in A. afra and M. flabellifolius inhalation extracts at retention time 
4.67 minutes (Table 3.1). It is this same compound that is common in all three extracts 
(inhalation, methanol and acetone) of the plant M. flabellifolius at retention time 4.67 minutes 
and is clearly observed as a common peak in Figure 3.6. There is also a common compound 
seen in all five inhalation extracts at retention time 12.08 minutes (Table 3.1). 
 
In
te
n
si
ty
0.00
0.50
1.00
1.50
2.00
Minutes
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00
 
Figure 3.23: HPLC-MS chromatogram of T. camphoratus inhalation extract. 
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Figure 3.24: HPLC-MS chromatogram of M. flabellifolius inhalation extract. 
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Figure 3.25: HPLC-MS chromatogram of P. calomelanos inhalation extract. 
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Figure 3.26: HPLC-MS chromatogram of H. natalensis inhalation extract. 
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Figure 3.27: HPLC-MS chromatogram of A. afra inhalation extract.  
 
A comparison of the HPLC-MS inhalation chromatograms revealed that combustion may 
produce some common compounds but each extract also has unique compounds. HPLC-MS 
chromatograms revealed six compounds that are common to all five of the inhalation 
samples, i.e. the compounds at retention times, 3.97, 5.38, 26.14, 31.95, 43.66, and 47.28 
minutes. However, out of the 90 compounds found in the five inhalation samples during 
HPLC-MS analysis only the above six were common. Out of the 90 compounds found in the 
inhalation samples, 16 compounds are unique to a particular extract and are absent in all other 
samples. Ten unique compounds are only found in the A. afra inhalation extract and six 
unique compounds are only found in the P. calomelanos inhalation extract. 
 
3.1.4. General discussion of the chemical composition 
 
Chromatographic profiles provide a comparison of the various extracts/samples for each 
plant. It is interesting to note the differences in the chromatograms for the same plant. These 
differences highlight two important points: first, the solvent used for extraction has a major 
impact on the compounds extracted from the plant material; and, secondly, the process of 
burning has a profound impact on the chemistry. It is also clear that the inhalation samples 
produced very different chromatograms from the methanol and acetone extracts of the same 
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plant, especially evident when examining the HPLC-UV and HPLC-MS chromatograms of 
Artemisia afra, Pellaea calomelanos, and Tarchonanthus camphoratus.   
 
Whether the burning of all plant material generates the same active compounds has been a 
topic of debate. Van Staden et al. (1995) reported that similar compounds are found in smoke 
extracts derived from different plants. A comparison allowed the identification of 12 
compounds of which seven were common in the two extracts investigated by Van Staden et 
al. (1995). There were some common compounds found in this study as would be expected; 
e.g. M. flabellifolius and P. calomelanos inhalation extracts have two common compounds at 
retention times of 5.59 and 18.89 minutes observed from the HPLC-UV chromatograms 
(Table 3.1) and the same compounds were present on the HPLC-MS chromatograms at 
retention times 16.20 and 37.11 minutes (Figures 3.25 and 3.24). A. afra and T. camphoratus 
inhalation extracts have one common compound found at retention time 32.86 minutes (Table 
3.1). P. calomelanos and T. camphoratus inhalation extracts also have one common 
compound at retention time 12.03 minutes (Table 3.1).  However, there were no compounds 
found to be common to all five inhalation extracts when the HPLC-UV chromatographic 
profiles of the five inhalation samples were compared (Figure 3.22). The HPLC-UV analysis 
of the five inhalation extracts showed different chromatograms (Figure 3.22), indicating that 
burning does not produce the exact same compounds regardless of the plant, although certain 
common constituents are noted between one or two of the extracts. A total of  74 out of the 
78 compounds found in the inhalation samples in the HPLC-UV analysis were unique and 
were absent in all other plant extracts. Minorsky (2002) noted that not all smoke derived from 
individual species is equally effective in promoting seed germination, thus there must be 
differences in chemical composition.  
 
One interesting observation from the HPLC-MS analysis is the common compounds that 
occur in the H. natalensis inhalation sample and the T. camphoratus inhalation sample, i.e. at 
retention times: 3.92, 5.43, 14.82, 17.28, 18.14, 32.76, 35.02, 38.56, 41.24, 47.37 and 49.17 
minutes (Figures 3.5  and 3.21). Common compounds are also found in the methanol and the 
acetone samples of the same two plants, namely: H. natalensis and T. camphoratus at 
retention times 3.93, 4.04, 5.32, 23.94, 27.07, 31.22, 43.15, 44.98 and 46.05 minutes (Figures 
3.3, 3.4, 3.19, 3.20). These distinct structural similarities in the HPLC-MS chromatograms of 
the two plants, H. natalensis and T. camphorates, did not, however, correlate with any of the 
antimicrobial data.  
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Besides the extensive HPLC-UV and HPLC-MS analysis performed above, gas 
chromatography may have also been valuable in elucidating the compounds responsible for 
enhanced antimicrobial effects observed during antimicrobial testing. A few of the selected 
species in this investigation are rich in volatiles and would ideally have been analysed using 
gas chromatography (GC). However, because of the high carbon content and high molecular 
weights of the compounds formed during combustion, an initial attempt to achieve good GC 
profiles proved impossible. In addition, the compounds formed seemed to have extremely 
high boiling points and proved difficult to vaporise during a trial analysis of two of the 
inhalation samples. For the above mentioned reasons, however, gas chromatography was not 
used to analyse the samples under investigation. 
 
3.2 Antimicrobial activity of extracts 
 
The minimum inhibitory concentration (MIC) was used to quantitatively measure the in vitro 
antibacterial activity of the test extracts before and after burning.  Bioassays facilitated an 
interesting comparison of the antimicrobial activities of inhalation extracts compared to those 
of the conventional solvent extracts of the same plants. Table 3.2 shows the results obtained 
from the antimicrobial testing. 
 
Table 3.2: The MIC values for combustion, methanol, acetone and water extracts and isolated 
essential oils (mg/ml): (Ciprofloxacin was used as the control for the bacterial pathogens and 
amphotericin B was used as the control for C. neoformans). 
Sample S. aureus 
(ATCC 25923) 
B. cereus 
(ATCC 11778) 
K. pneumoniae 
(ATCC 9633) 
C. neoformans 
(ATCC 90112) 
H. natalensis     
Inhalation 1.86 0.35 0.70 0.93 
Methanol 0.38 0.25 1.00 0.83 
Acetone 0.38 0.25 2.00 1.50 
Water 4.00 1.50 2.00 4.00 
Essential oil 32.00 4.00 8.00 8.00 
M. flabellifolius    
Inhalation 0.72 0.27 0.36 0.36 
Methanol 4.00 3.00 3.00 1.00 
Acetone 1.00 0.50 1.50 0.25 
Water 4.00 8.00 6.00 0.75 
Essential oil 6.00 2.00 3.00 3.30 
A. afra     
Inhalation 0.52 0.26 0.52 0.52 
Methanol 2.00 1.00 3.00 2.00 
Acetone 0.25 0.25 2.00 0.75 
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Sample S. aureus 
(ATCC 25923) 
B. cereus 
(ATCC 11778) 
K. pneumoniae 
(ATCC 9633) 
C. neoformans 
(ATCC 90112) 
Water 4.00 4.00 4.00 4.00 
Essential oil 16.00 12.00 8.00 32.00 
P. calomelanos    
Inhalation 0.53 1.00 0.53 0.53 
Methanol >16.00 >16.00 6.00 4.00 
Acetone 2.00 4.00 1.50 >32.00 
Water >16.00 >16.00 16.00 4.00 
T. camphoratus    
Inhalation 0.62 0.23 0.93 0.47 
Methanol 2.00 1.00 3.00 1.00 
Acetone 0.50 <0.13 1.50 0.38 
Water 8.00 6.00 8.00 >32.00 
Essential oil 4.00 0.75 6.00 6.60 
Positive controls (commercial antibiotic) 
 
0.5 x 10-3 2.5 x 10-3 0.8 x 10-3 1.25 x 10-3 
Blank controls (solvent) 
 Methanol 16.0 16.0 8.0 8.0 
 Acetone No activity No activity No activity No activity 
Water No activity No activity No activity No activity 
 
The results tabulated above are graphically represented for each species in Figures 3.28 – 
3.32.  
3.2.1. Heteropyxis natalensis 
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Figure 3.28: MIC values (mg/ml) for extracts and essential oils of H. natalensis tested against 
four pathogens. 
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The inhalation extract of H. natalensis exhibited MIC values lower than the essential 
oil and water extracts in all cases when antimicrobial testing was done against the 
above four pathogens. The inhalation extract of H. natalensis was a stronger 
antimicrobial than all other extracts of this plant when tested against K. pneumoniae, 
which is one of the bacterial pathogens isolated in patients with an acute exacerbation 
of chronic bronchitis and in bacterial pneumonia cases (Dipiro et al., 2002). Bacterial 
pneumonia is indeed a respiratory condition suited for treatment through inhalation 
therapy. The inhalation extract demonstrated low MIC values against all pathogens 
(Figure 3.28 and Table 3.2). However, it was not as strong an antimicrobial as either 
the methanol or acetone extracts of the plant for the pathogens S. aureus, B. cereus, 
and C. neoformans. The MIC results for the acetone and methanol extracts also gave 
exactly the same MIC values for these two samples when tested against S. aureus and 
B. cereus (Table 3.2) and this is worth noting because there were obvious similarities 
between the acetone and the methanol chromatographic profiles (Figure 3.3 and 
Figure 3.4).  
 
3.2.2. Myrothamnus flabellifolius 
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Figure 3.29: MIC values (mg/ml) for extracts and essential oils of M. flabellifolius tested 
against four pathogens. 
  
The inhalation extract of Myrothamnus flabellifolius had lower MICs than the methanol, 
acetone, water, and essential oil extracts of the plant, when tested against all the pathogens 
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with the exception of Cryptococcus neoformans (Figure 3.29 and Table 3.2). The abundance 
of peaks late in the HPLC-MS chromatogram (Figure 3.9) may play a role in the enhanced 
activity observed for the M. flabellifolius inhalation extract.  
 
Another interesting observation is the low MIC values obtained for all Myrothamnus 
flabellifolius extracts when tested against Cryptococcus neoformans. The average MIC value 
for all M. flabellifolius extracts is far lower against C. neoformans than against any of the 
other pathogens. It seems that M. flabellifolius is more active against the yeast than a 
bacterial pathogen. A Cryptococcus neoformans respiratory infection is a chronic infection 
which involves mainly the lungs and meninges, and traditional practices have seen 
Myrothamnus flabellifolius smoke inhaled to treat chest complaints and infections 
(Hutchings, 1996; van Wyk et al., 1997). Strong antimicrobial activity was also found when 
M. flabellifolius was tested against yeast/fungal pathogens in a study by Viljoen et al. (2002). 
Another testament to the use of this plant for respiratory ailments is the current use of one of 
its essential oil components (trans-pinocarveol) in a commercial pharmaceutical preparation 
called Ozopulmin to treat respiratory conditions (Viljoen et al., 2002).  
 
3.2.3. Artemisia afra 
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Figure 3.30: MIC values (mg/ml) for extracts and essential oils of A. afra tested against four 
pathogens. 
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The inhalation extract of A. afra had the lowest MIC when compared to the other extracts of 
the plant tested against K. pneumoniae and C. neoformans (Figure 3.30 and Table 3.2).  
Artemisia afra is also a plant that has been shown throughout the literature to demonstrate 
high antimycotic (‘anti-fungal and anti-yeast’) potency. It has been said that A. afra has 
greater activity as an antimycotic agent than as an antibacterial agent (Graven et al., 1992). 
This antimycotic superiority over an antibacterial effect was not evident in this study for 
Artemisia afra, as the plant demonstrated an equally effective antimicrobial effect against the 
bacterial pathogens as it did against the yeast C. neoformans. A study done by Gundidza 
(1993) clearly indicated Artemisia afra’s strong inhibitory effect on seven out of ten fungi 
tested in this earlier study. In addition, various studies note the susceptibility of the 
mycotoxigenic strain Aspergillus ochraceus to A. afra essential oil (Graven et al., 1992; 
Gundidza, 1993). In contrast, this particular study demonstrated a very high MIC of 32.00 
mg/ml for the essential oil of A. afra against the yeast C. neoformans (Figure 3.30 and Table 
3.2).  
 
 It is clear that the inhalation extract of A. afra was a stronger antimicrobial than the other 
solvent extracts when tested against C. neoformans (MIC 0.52 mg/ml), and was also a more 
potent antibacterial agent than its conventional solvent extracts when tested against K. 
pneumoniae (MIC 0.52 mg/ml) (Table 3.2). The unique early eluting peaks and, in particular, 
the major peak observed in the inhalation sample (HPLC-UV) chromatogram at retention 
time 5.46 minutes (integration area of 34.18%) (Table 3.1 and Figure 3.10) may shed light on 
the MIC potency observed when the A. afra inhalation extract was tested against K. 
pneumonia and C. neoformans.  
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3.2.4. Pellaea calomelanos 
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Figure 3.31: MIC values (mg/ml) for extracts of P. calomelanos tested against four pathogens  
 
The inhalation extract of P. calomelanos had the lowest MIC results compared to its 
respective extracts for all pathogens tested (Figure 3.31 and Table 3.2). The superior MIC 
values obtained for Pellaea calomelanos may be linked to the presence of unique compounds 
found in the inhalation sample as seen in the chemical comparison of the extracts. In the 
HPLC-UV chromatogram (Figure 3.14), two unique peaks are observed at retention times 
9.62 minutes and 14.08 minutes and are only present in the inhalation sample (Figure 3.14 
and Table 3.1). 
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3.2.5. Tarchonanthus camphoratus 
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Figure 3.32 (13): MIC values (mg/ml) for extracts and essential oils of T. camphoratus tested 
against four pathogens. 
 
The Tarchonanthus camphoratus inhalation extract had a lower MIC value compared to all 
other extracts of the plant when tested against Klebsiella pneumoniae (MIC 0.93 mg/ml). 
Generally, the inhalation extracts of this plant had low MIC values, only the acetone extracts 
showed a lower MIC than the inhalation sample for the other three pathogens (Figure 3.32 
and Table 3.2). Significant peaks seen early in the HPLC-UV profile (Figure 3.18) of the 
inhalation extract were found to be unique to this extract. Noticeable peaks were also 
observed late in the HPLC-MS chromatogram (Figure 3.21). Perhaps these chemical 
differences observed in the UV chromatograms and the MS chromatograms of the various 
extracts may account for the enhanced antimicrobial activity recorded for the inhalation 
extract for Klebsiella pneumoniae (Figure3.32 and Table 3.2). 
 
3.2.6. General discussion of antimicrobial activity 
 
Many inhalation extracts had low MIC values, which highlighted their superior antimicrobial 
potency when compared to the solvent and aqueous extracts and the essential oils of the 
aromatic plants. The inhalation extract was more potent than any of its respective 
conventional extracts in a number of cases; A. afra tested against K. pneumoniae (0.52 
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mg/ml); P. calomelanos tested against K. pneumoniae (0.53 mg/ml); A. afra tested against C. 
neoformans (0.52 mg/ml); and M. flabellifolius tested against B. cereus (0.27 mg/ml). 
 
A pronounced increase in antimicrobial activity is shown after combustion in a number of 
cases; e.g. M. flabellifolius samples tested against S. aureus;  essential oil MIC (6.00 mg/ml), 
water MIC (4.00 mg/ml), methanol MIC (4.00 mg/ml), acetone MIC (1.00 mg/ml), and 
inhalation sample MIC (0.72 mg/ml). This increase in antimicrobial effect is observed also 
when M. flabellifolius was tested against all four pathogens, with the inhalation sample 
proving the most potent in all cases (except for C. neoformans). In a second instance, the 
inhalation extract of a plant proved more potent than any other sample of that same plant 
when tested against a particular pathogen; e.g. H. natalensis vs. K. pneumoniae MIC’s: 
inhalation sample (0.70 mg/ml), methanol (1.00 mg/ml), water (2.00 mg/ml), acetone (2.00 
mg/ml), essential oil (8.00 mg/ml). An important observation is noted for P. calomelanos, 
where the inhalation extract demonstrated greater antimicrobial activity than all of its solvent 
extracts against all 4 pathogens tested. 
  
In the case of Klebsiella pneumoniae, all five inhalation extracts exhibit stronger 
antimicrobial activity than their respective conventional extracts: H. natalensis (0.70 mg/ml), 
M. flabellifolius (0.36 mg/ml), A. afra (0.52 mg/ml), P. calomelanos (0.53 mg/ml), and T. 
camphoratus (0.93 mg/ml). Klebsiella pneumoniae is one of the bacterial pathogens isolated 
in patients with an acute exacerbation of chronic bronchitis and in bacterial pneumonia cases. 
Enteric Gram-negative bacteria are the leading causes of nosocomial pneumonia according to 
Dipiro et al. (2002). It is relevant to note that Klebsiella pneumoniae is the most frequently 
encountered pathogen in this community-acquired enteric gram-negative pneumonia. This 
type of pneumonia is identified commonly among patients with chronic illness (diabetes 
mellitus and alcoholism), and is associated with high mortality (>50% in some cases).  The 
potential of K. pneumoniae and other Gram-negative bacilli to produce extensive morbidity 
and mortality is enhanced by the emergence of highly resistant organisms (Dipiro et al., 
2002). The strong antimicrobial effect observed for the inhalation samples against this 
dangerous pathogen may be useful in drug development and in the quest to enhance treatment 
efficacy. 
 
Testing against the pathogen S. aureus revealed that the M. flabellifolius and P. calomelanos 
inhalation extracts were the strongest antimicrobials when compared to all their respective 
laboratory control extracts. M. flabellifolius inhalation MIC was 0.72 mg/ml and P. 
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calomelanos inhalation MIC was 0.53 mg/ml. In the case of the results of H. natalensis, A. 
afra, and T. camphoratus obtained with S. aureus, only their acetone samples were superior 
in antimicrobial strength to the inhalation extracts. 
 
Results obtained for B. cereus were similar to those recorded for S. aureus. The M. 
flabellifolius and P. calomelanos inhalation extracts had superior antimicrobial activity than 
their respective solvent extracts (M. flabellifolius inhalation MIC was 0.27 mg/ml and P. 
calomelanos inhalation MIC was 1.00 mg/ml). Only the acetone extracts were more active 
than the inhalation extracts in terms of antimicrobial potency for H. natalensis, A. afra, and T. 
camphoratus. 
 
The results for C. neoformans demonstrated the lowest MIC values for the inhalation extracts 
of two plants, i.e. A. afra and P. calomelanos, when compared to their respective methanol, 
water, and acetone extracts, and compared to their essential oils. In other words, the 
inhalation extracts of A. afra and P. calomelanos were more potent than the plants’ 
conventional solvent extracts with this particular pathogen. The acetone extracts 
demonstrated better MIC values than all others for T. camphoratus and M. flabellifolius when 
tested against C. neoformans. The methanol extract of H. natalensis was the most potent 
extract, followed by the inhalation sample (MIC 0.83 mg/ml and 0.93 mg/ml respectively) 
when tested against Cryptococcus neoformans. 
 
On average, the conventional solvent extracts showed higher MIC values and were less 
potent than the inhalation extracts; e.g. average MIC for methanol, acetone, water and 
essential oil extracts of M. flabellifolius and B. cereus were 3.38 mg/ml compared to 0.27 
mg/ml for the inhalation sample.  
 
Generally, acetone extracts were shown to have extremely low MIC’s. It seemed evident that 
inhalation and acetone extracts were comparable in terms of antimicrobial efficacy, yet there 
is a large quantitative difference between inhalation extracts and the other solvent extracts 
(methanol, water and essential oil). This is an interesting finding considering that previous 
work supports the theory that solvent extracts may actually be superior to traditionally 
prepared extracts (Jäger, 2003). The study by Jäger (2003) raised concerns about the 
traditional way of preparing plant extracts and concluded that the traditional means of 
preparation may not lead to very active extracts. In the current study, however, the inhalation 
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extracts (products of a crude method of traditional preparation of plant remedies) were in fact 
very active, with low MICs indicating that the active compounds were retained.  
 
Rabe and van Staden (1997) reported that the majority of the antibacterial activity of plants 
was present in methanol extracts. Traditionally, however, plant extracts are prepared with 
water and it seems unlikely for traditional healers to extract those constituents that are 
responsible for activity in the methanol extracts (Rabe and van Staden, 1997).  
 
It is also highly unlikely and impractical for traditional healers to extract plants with acetone. 
This study has shown strong antimicrobial activity with the acetone extracts and the 
inhalation extracts. Acetone is very efficient as a solvent for extracting compounds with high 
antimicrobial activity (Eloff, 1998b). Eloff (1998b) conducted a study to evaluate which 
extractant should be used for the screening and isolation of antimicrobial components from 
plants. That study concluded that acetone was by far the best and most useful solvent as it 
extracts polar and non-polar inhibitors and demonstrated the lowest MIC’s. This present 
study has confirmed Eloff’s (1998b) evaluation of acetone by also demonstrating high 
antimicrobial activity with the acetone extracts. It follows, therefore, that one should raise the 
question as to whether in vitro antimicrobial studies can be used to scientifically confirm 
theories about traditional practices, if traditional healers do not use ‘superior’ extractants like 
acetone.  
 
The essential oils, together with the GC-MS profile for this study was obtained from the 
research collaborator Dr. van Vuuren (van Vuuren, 2007). The antimicrobial activity of 
essential oils was initially evaluated in the liquid phase until a systematic evaluation of the 
vapour activity was carried out by Maruzella et al. (1959) and Kienholz (1959), and then by 
Maruzella and Sircurella (1960). The role of essential oils in inhalation therapy was further 
investigated by Inouye et al. (2001), who derived a method to express the antimicrobial 
activity by gaseous contact. A parameter called the MID (minimal inhibitory dose per unit 
space) was introduced to compare the relative vapour activity of essential oils. In comparison, 
this study has successfully created a novel way to mimic more closely what happens in a 
traditional setting with the specially designed inhalation apparatus, but a similar indicator 
such as the MID used by Inouye et al. (2001) may be useful in further quantifying the 
antimicrobial strength of the plant inhalation extracts. Embarking on a similar study to that 
conducted by Inouye et al. (2001), where smoke instead of essential oil vapour is allowed to 
impregnate into agar which contains respiratory pathogens, may shed more light on the 
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antimicrobial effects of smoke-derived constituents. Also of interest would be the 
solubility/absorption into an aqueous medium such as agar. 
   
Various factors may also influence the antibacterial effect of inhaled substances as a viable 
therapy. Time of exposure to the inhaled smoke, the concentration of ‘gas’ produced, the heat 
of combustion and the mode of burning (open fire, electric stove, gas stove) may all influence 
the effect achieved. Some studies on the inhalation of essential oils concluded that the 
antimicrobial action by gaseous contact is most efficient when the pathogen is exposed at 
high vapour concentration for a short time (Inouye et al., 2001). Various temperatures may 
produce different compounds with changing activities. Slow combustion of dry or green plant 
material gives rise to the active principles that are apparently produced around 160-200°C 
and are volatilised at higher temperatures (Minorsky, 2002). 
 
The antimicrobial activity of all volatile compounds is a result of two factors: the direct 
vapour absorption on microorganisms; and an indirect effect through the medium that 
absorbed the vapour (Moleyar and Narasimham, 1986).  
 
 The MIC results indicate that active compounds are formed on combustion and these 
constituents, only present after burning, have enhanced antimicrobial activity. Similarly, 
Minorsky (2002) commented on smoke-derived germination cues having high activity at very 
low concentrations (e.g. Nicotiana attenuata was active at concentrations < 1pg/seed). A 
study done by van Staden et al. (2004) investigated the role of smoke-derived fractions as a 
germination stimulant. Plant-derived smoke does indeed contain several thousand different 
compounds and it is generally accepted that active constituents are produced directly by the 
combustion of the plant material (van Staden et al., 2004). It may be postulated that the 
phytoconstituents formed on combustion serve to enhance the antimicrobial activity of the 
plant (a synergistic or additive effect), or that new antimicrobial compounds are formed 
(artefacts) that enhance activity. Smoke extracts have already found wide application as seed 
germination stimulants, in that they have been used as seed pretreatments for enhancing the 
conservation of threatened or rare species of plants (Minorsky, 2002).  In addition, smoke-
induced germination studies have shown a long-lasting ability of plant smoke to overcome 
seed dormancy. Seeds treated with smoke have retained an enhanced ability to germinate 
even after a year of storage (Minorsky, 2002). Perhaps the improved germination ability 
(Minorsky, 2002) is as a result of the enhanced antimicrobial activity found in the inhalation 
extracts in the current study (Table 3.2) 
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It has also been noted that the degradation of certain essential oil components (limonene and 
α-pinene) by oxidation may produce oxygenated products that exhibit better activity than the 
parent hydrocarbons (Inouye et al., 2001). Adriansz et al. (2000) identified 1,8-cineole as an 
active germination enhancer, and octanoic acid was identified as an active factor in smoke in 
another study (Sutcliffe and Whitehead, 1995). The exact compounds responsible for the 
antimicrobial activity would need to be identified and isolated in similar future studies. The 
promising MIC values documented after combustion and the known benefits of site-specific 
administration could explain the benefits of inhalation therapy in traditional medicine for 
treating respiratory ailments.  
 
3.3. General discussion 
 
Out of the 90 compounds found in the inhalation samples during HPLC-MS, 16 compounds 
are unique to a particular extract and do not occur in any other sample; ten compounds are 
found only in A. afra inhalation extract and six compounds are found only in P. calomelanos 
inhalation extract and no other extract. It could be postulated that it is these unique 
compounds that account for the antimicrobial potency of the A. afra inhalation extract when 
tested against K. pneumoniae and C. neoformans.  
 
Another interesting finding was the occurrence of the same compounds in M. flabellifolius 
inhalation sample and P. calomelanos inhalation sample at retention times 16.20 and 37.11 
minutes during HPLC-MS analysis. M. flabellifolius and P. calomelanos inhalation extracts 
also have two common compounds at retention times of 5.59 and 18.89 minutes (Table 3.1). 
These similarities are pertinent as the M. flabellifolius inhalation sample had the strongest 
antimicrobial effect when compared to its respective methanol, acetone, water and essential 
oil samples when tested against all pathogens except one (C. neoformans). As discussed 
previously, the P. calomelanos inhalation sample was also superior to all other conventional 
extracts of this plant when tested against all four pathogens. It is interesting that these two 
plants have shown higher antimicrobial potency in nearly all cases with the inhalation 
extracts compared to their respective solvent extracts (Table 3.2). 
 
Despite the need for further investigation into isolating the exact constituents responsible for 
the low MIC values of the inhalation extracts, work also needs to be done on the possible role 
of a physical mechanism that occurs in a patient when inhaling a vapour. Investigation into 
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the exact physical mechanism of action of smoke-derived constituents may further explain 
the superiority of this mode of administration. Many inhaled medicines are used to treat colds 
and respiratory conditions, and essential oil inhalation has long been used to treat acute and 
chronic bronchitis, sinusitis, and other respiratory conditions (Inouye et al., 2001). It has been 
said that the vapours of essential oils increase the outflow of respiratory tract fluid (Boyd and 
Sheppard, 1970), maintain the ventilation drainage of the sinuses (Burrow et al., 1983), and 
have an anti-inflammatory effect on the trachea (Shubina et al., 1990), in addition to their 
antibacterial activities. Perhaps smoke inhalation has a similar mechanical effect on the 
tissues, in addition to its enhanced antimicrobial effect.   
 
In an age of modern advances in the medical field many rural folk still use inhalation as a 
means of treatment not only because they lack the finances to seek allopathic cures but 
because of their belief in its efficacy.  Inhalation is a highly effective mode of administration 
not only because of its direct and local effect on the lungs for the treatment of respiratory 
afflictions, but also because of its ability to deliver drugs effectively to the rest of the body. In 
addition, the large surface area for absorption and the low metabolic activity of the lungs 
make this organ system a potential route for systemic delivery of drugs that cannot be 
administered by other means (Suarez and Hickey, 2000). A few studies have shown that the 
lungs provide a substantially greater bioavailability for macromolecules than any other port 
of entry to the body (Suarez and Hickey, 2000). 
  
The need for further investigations into this interesting area of study is evident. An interesting 
area for future study into inhalation therapy might be an investigation of bacterial vs. fungal 
susceptibility towards inhalation extracts. Even work done with inhalation extracts 
concentrating only on fungal pathogens would be valuable.  Further MICs, in conjunction 
with more advanced structural analysis and careful isolation of the active compounds in 
inhalation extracts, would be helpful in revealing the exact compounds responsible for the 
enhanced antimicrobial effects, and this would shed more light on inhalation as an effective 
and extensively utilised method of treatment in both western and traditional cultures. 
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CHAPTER 4: CONCLUSIONS 
 
• The inhalation extracts had extremely low MIC values emphasising their antimicrobial 
potency against respiratory pathogens. The MIC’s of the inhalation extracts ranged 
between 0.23 mg/ml (T. camphoratus for. B. cereus) to 1.86 mg/ml (H. natalensis for  S. 
aureus). All inhalation extracts had MIC values that on average are lower than the 
average MIC obtained for the solvent extract.  
• When comparing inhalation extracts to conventional solvent extracts, a dramatic change 
in antimicrobial activity and composition was evident. In specific cases the inhalation 
extract of a plant was stronger as an antimicrobial against certain pathogens than any of 
the other conventional solvent extracts of that same plant. This superior activity of the 
inhalation extract was observed for M. flabellifolius when tested against all pathogens 
(except for C. neoformans). Pellaea calomelanos inhalation extract had the lowest MIC 
values when compared to the solvent extracts for all pathogens.  
• All five inhalation extracts demonstrated stronger antimicrobial activity than their 
respective solvent and aqueous extracts when tested against Klebsiella pneumoniae. 
• Chromatographic profiles revealed a difference in composition between different extracts 
of the same plant. 
• Inhalation extracts gave rise to a very different chemical profiles compared to the solvent 
extracts of the same plants, and inhalation samples contained a number of unique 
compounds not present in the other extracts. HPLC-MS profiles revealed that of the 90 
compounds noted in the inhalation samples, 16 compounds are unique and do not occur in 
any other sample. It is clear that combustion process produces compounds not present in 
any of the solvent extracts.  
• HPLC comparisons of the five inhalation extracts revealed that similar and different 
constituents are formed during the burning process and that combustion does not liberate 
the same compounds regardless of the plant material. 
• The choice of solvent used for extraction and the burning process greatly influences the 
chemical composition and the observed antimicrobial activity.  
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APPENDIX 
 
A presentation was given at The Indigenous Plant Use Forum, Grahamstown, 27-30 June 
2005 [Podium presentation] where some of the data on the plant Pellaea calomelanos was 
presented. 
 
“Some variables to be considered in pharmacognostic studies using South African 
medicinal plants as a demonstration model” 
 
S. VAN VUUREN, A. VILJOEN, R. VAN ZYL, E. NJENGA AND M. BRAITHWAITE  
Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the 
Witwatersrand, 7 York Road, Parktown 2193, South Africa.  
 
Many variables are involved in plant-based studies and microbiological assays are only as 
reliable and sensitive as the test system employed. Using South African medicinal plants, 
some aspects of Pharmacognosy studies will be highlighted to demonstrate the factors that 
may influence the results.  
Joint assays may corroborate findings, as in the case of Osmitopsis asteriscoides where 
results obtained from disc diffusion, MIC, time-kill methodology and confocal membrane 
integrity studies are congruent. Studies on Eriocephalus spp. however, reveal that the choice 
of assay can change the whole focus of the results. Geographical and /or genetic factors may 
account for variation within and between plant populations as seen with antimicrobial data 
generated for Eriocephalus aromaticus. Seasonal variation may or may not impact on the 
results obtained, as noted in a study on Heteropyxis natalensis, where plants were harvested 
on a monthly basis for one year. The MIC values obtained from individual plants indicated 
little variation. However, the ratio of the two major compounds (1,8-cineole and limonene) 
showed some monthly fluctuation. The role these two compounds have on the overall 
antimicrobial activity was assessed and results indicate that in combination they show 
variable synergistic and antagonistic interaction. The traditional use of plants as a treatment 
for infectious diseases is not always restricted to a single plant part.  Antimicrobial studies on 
Croton gratissimus show that not only do the leaf, bark and root extracts have higher 
sensitivities than the essential oils, but that in root/leaf combination, synergy is enhanced. 
Using a simple combustion experiment for plants of which the smoke is inhaled we have 
illustrated that the smoke fraction is antimicrobially more active than the solvent extracts.  
This clearly demonstrates the need to mimic the traditional mode of administration as closely 
as possible in the laboratory. 
 
 
 
 
 
 
 
 
 
